Oriowo M A, Hieble J P, Ruffolo R R
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pa.
Pharmacology. 1991;43(1):1-13. doi: 10.1159/000138821.
The interactions between SK&F 104078 and several selective alpha 2-adrenoceptor agonists at pre- and postjunctional alpha 2-adrenoceptors were investigated in order to assess the previously reported selectivity of SK&F 104078 for postjunctional alpha 2-adrenoceptors and to determine whether or not SK&F 104078 could uncover subtypes of alpha 2-adrenoceptors located prejunctionally as has also been suggested. The alpha 2-adrenoceptor agonists, UK 14,304, xylazine, B-HT 933, B-HT 920, clonidine and M-7, produced concentration-dependent prejunctional alpha 2-adrenoceptor-mediated inhibition of neurogenic responses in the guinea pig atrium and rat vas deferens and produced postjunctional alpha 2-adrenoceptor-mediated contraction of the canine saphenous vein. The alpha 2-adrenoceptor antagonist, rauwolscine, blocked all the agonists at both pre- and postjunctional alpha 2-adrenoceptors without demonstrating preference for any agonist or any synaptic location of alpha 2-adrenoceptors. In marked contrast, SK&F 104078 produced equivalent antagonism of all agonists in the canine saphenous vein but had no significant effect against the same agonists in the guinea pig atrium, suggesting a high degree of selectivity for postjunctional alpha 2-adrenoceptors in these test systems, consistent with our previous observations. In the rat vas deferens, however, SK&F 104078 significantly antagonized the prejunctional alpha 2-adrenoceptor-mediated effects of clonidine and M-7 but did not block the responses to UK 14,304, xylazine, B-HT 933 and B-HT 920. These results indicate that the prejunctional alpha 2-adrenoceptor antagonist effects of SK&F 104078 are tissue and agonist dependent, and that there may be at least two subtypes of prejunctional alpha 2-adrenoceptors that can be discriminated with SK&F 104078 but not with rauwolscine. Both subtypes of prejunctional alpha 2-adrenoceptors may be present in the rat vas deferens, while only the SK&F-104078-insensitive subtype is present in the guinea pig atrium.
研究了SK&F 104078与几种选择性α2-肾上腺素能受体激动剂在节前和节后α2-肾上腺素能受体上的相互作用,以评估先前报道的SK&F 104078对节后α2-肾上腺素能受体的选择性,并确定SK&F 104078是否能揭示如之前所提示的位于节前的α2-肾上腺素能受体亚型。α2-肾上腺素能受体激动剂UK 14,304、赛拉嗪、B-HT 933、B-HT 920、可乐定和M-7,在豚鼠心房和大鼠输精管中产生浓度依赖性的节前α2-肾上腺素能受体介导的神经源性反应抑制,并在犬隐静脉中产生节后α2-肾上腺素能受体介导的收缩。α2-肾上腺素能受体拮抗剂育亨宾,在节前和节后α2-肾上腺素能受体上阻断所有激动剂,而不显示对任何激动剂或α2-肾上腺素能受体的任何突触位置有偏好。与之形成显著对比的是,SK&F 104078在犬隐静脉中对所有激动剂产生同等程度的拮抗作用,但对豚鼠心房中的相同激动剂无显著影响,这表明在这些测试系统中对节后α2-肾上腺素能受体具有高度选择性,与我们之前的观察结果一致。然而,在大鼠输精管中,SK&F 104078显著拮抗可乐定和M-7的节前α2-肾上腺素能受体介导的作用,但不阻断对UK 14,304、赛拉嗪、B-HT 933和B-HT 920的反应。这些结果表明,SK&F 104078的节前α2-肾上腺素能受体拮抗剂作用是组织和激动剂依赖性的,并且可能至少有两种节前α2-肾上腺素能受体亚型,它们可用SK&F 104078区分,但不能用育亨宾区分。两种节前α2-肾上腺素能受体亚型可能都存在于大鼠输精管中,而豚鼠心房中仅存在对SK&F-104078不敏感的亚型。